Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Markers of Adequate Pubertal Suppression During Supprelin LA Therapy for Central Precocious Puberty

NCT02006680 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT02006680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02006680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Markers of Adequate Pubertal Suppression During Supprelin LA Therapy for Central Precocious Puberty
Lead sponsor
University of Minnesota
Phase
Observational
Overall status
Terminated
Start date
December 31, 2013
Completion date
December 31, 2015
Enrollment
4 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

central precocious puberty